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Abstract
Background: Retrotransposons have been extensively studied in plants and animals and have been shown to
have an impact on human genome dynamics and evolution. Their ability to move within genomes gives
retrotransposons to affect genome instability.
Methods: we examined the polymorphic inserted AluYa5, evolutionary young Alu, in the progesterone receptor
gene to determine the effects of Alu insertion on molecular environment. We used mono-allelic inserted cell lines
which carry both Alu-present and Alu-absent alleles. To determine the epigenetic change and gene expression, we
performed restriction enzyme digestion, Pyrosequencing, and Chromatin Immunoprecipitation.
Results: We observed that the polymorphic insertion of evolutionally young Alu causes increasing levels of DNA
methylation in the surrounding genomic area and generates inactive histone tail modifications. Consequently the
Alu insertion deleteriously inactivates the neighboring gene expression.
Conclusion: The mono-allelic Alu insertion cell line clearly showed that polymorphic inserted repetitive elements
cause the inactivation of neighboring gene expression, bringing aberrant epigenetic changes.
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Background
Retrotransposons have been extensively studied in plants
and animals and have been shown to have an impact on
human genome dynamics and evolution. About 42% of
the human genome contains retrotransposons while DNA
transposons account for around 2-3% [1-3]. According to
the 2001 analysis, which has been confirmed overall by the
2004 update (International Human Genome Sequencing
Consortium 2004), short interspersed elements (SINEs),
such as Alu or SINE-R/VNTR/Alu (SVA), account for
13%, Long interspersed elements [LINE-1(L1)] for 20%,
and long-terminal repeat (LTR) retrotransposons, such as
endogenous retrovirus (ERV), for 8%, respectively, of the
sequenced human genome. The retrotransposons increase
their copy number by retrotransposition via RNA.
Attempted or successful retrotranspositions carry a high
risk of eliciting chromosome breaks, deletions, transloca-
tions, and recombinations [4]. It is estimated that there is
one Alu retrotransposon insertion every 21 births [5] dur-
ing gametogenesis, transferring the retrotransposon’s
genetic information to the next generation [6,7]. These
retrotransposition events are likely to change the activity
of genes at the insertion site, including increased or
decreased transcriptional activity. In some cases, this
alteration of gene expression causes the development of
several diseases or cancers [8]. DNA methylation on the
retrotransposon is thought to be the mechanism that con-
trols the retrotransposition rate. Recent vast numbers of
publications uniformly address that complex disease, can-
cer, aging, and environmental challenges are associated
with aberrant retrotransposon DNA methylation.
In fact, not all retrotransposons have the capability to
retrotranspose to other genomic locations. Currently,
most L1s are inactive and cannot retrotranspose to new
genomic locations [9], while a small number of human
* Correspondence: hmbyun@hsph.harvard.edu
1Jane Anne Nohl Division of Hematology, Norris Comprehensive Cancer
Center, Keck School of Medicine, University of Southern California, Los
Angeles, California, USA
Full list of author information is available at the end of the article
Byun et al. Journal of Biomedical Science 2012, 19:13
http://www.jbiomedsci.com/content/19/1/13
© 2012 Byun et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.specific L1 (L1HS) elements remain retrotransposition
competent. Retrotransposons seeded in the human gen-
ome several million years ago and have many subfami-
lies defined by distinct patterns of diagnostic base
substitutions. Subfamilies may be classified as young,
intermediate or old, reflecting the time since the start of
retroposition by their members. The expansion of Alu
subfamilies (Yc1, Ya5, Ya2, Yb9, Yb8, Y, Sg1, Sx, and J;
young to old, respectively) is superimposed on primate
evolution. The evolutionally young L1, Alu,a n dS V A
are currently able to transpose in the human genome,
hence the ongoing retrotranspositional insertions of the
youngest subfamilies are not yet fixed in the human
genome and represent polymorphic loci [10]. Some
polymorphic insertions are known to be responsible for
more than 30 human genetic diseases [11-13]. A genetic
polymorphism names as PROGINS has been identified in
the progesterone receptor (PGR) gene with insertion of
Alu subfamily [14]. The correlations of Alu insertion
polymorphism on PGR gene are associated with endome-
triosis [15,16], ovarian cancer with diethylstilbestrol
exposure [17], breast cancer [18], and obesity [19]. Inser-
tional polymorphic retrotransposons are often observed
in a mono-allelic fashion, meaning retrotransposons are
inserted into only one of the alleles in individuals. For
instance, in chromosome 11, the PGR gene has a newly
inserted AluYa5 subfamily between exon 5 and 6. In this
study, we examine DNA methylation and histone modifi-
cation of the locus which occurred mono-allelic young
Alu, AluYa5 insertions and address the direct effect of
retrotransposon in controlling gene expression.
Methods
Nucleic acid isolation and bisulfite treatment
Genomic DNA was isolated by standard proteinase K
digestion and phenol-chloroform extraction [20]. Total
RNA was collected and extracted from cultured cells
with the RNeasy Protect minikit (QIAGEN Inc., Valencia,
CA) according to the manufacturer’s recommended pro-
tocol. Reverse transcription was performed by using the
f i r s ts t r a n dc D N As y n t h e s i sk i t( N E B ,B e v e r l y ,M A ,
USA). Bisulfite modification of genomic DNA has been
described previously [21]. PCR primer sequences for Alu
polymorphism with genomic DNA were forward:
TTGAGTAAAGCCTCTAAAAT and reverse: TTCTTG
CTAAATGTCTGTT, and with bisulfite DNA were for-
ward: GAAATTTGAAGGAAATAAATATTAGTGT
and reverse: CATTTAATTATCCAAAAATATTTTCT-
TAC TAA.
Quantitation of allele-specific gene expression by
Pyrosequencing
PCR products from genomic DNA or cDNA were used for
Pyrosequencing analysis as previously described [21].
Briefly, the PCR product of each gene was used for indivi-
dual sequencing reactions. Streptavidin-Sepharose beads
(Amersham Biosciences) and a Vacuum Prep Tool (Bio-
tage AB) were used to purify the single-stranded biotiny-
lated PCR products according to the manufacturer’s
recommendation. The appropriate sequencing primer was
annealed to the purified PCR product and used for a Pyro-
sequencing reaction using the PSQ 96HS system (Biotage).
Raw data were analyzed with the allele quantitation algo-
rithm using the PSQ 96 HS software. PCR primer
sequences for Alu polymorphism by Pyrosequencing were
forward: TTTTCGAAACTTACATATTGA, reverse biotin
labeled: TTTAGTATTAGATCAGGTGC, and sequencing
primer: GATCCTACAAACA. For allele-specific expres-
sion, forward primers: TAGTCAAGTGGTCTAAAT-
CATTGC, reverse biotin labeled: TTTAGTATTAGA
TCAGGTGC, and sequencing primer: GATCCTA-
CAAACA. To validate DNA methylation detection by
Pyrosequencing, we designed control oligo for 100% DNA
methylation (PSQ-C oligo: 5’- TATTAGATCGACGG-
GAACAAACGTTGAATTC -3’)a n d0 %D N Am e t h y l a -
tion (PSQ-T oligo: 5’- TATTAGATCAACGGGAACA
AACGTTGAATTC -3’). The sequencing primer for con-
trol oligo is 5’- CAACGTTTGTTCCCGT -3’.W em i x e d
PSQ-C oligo (or PSQ-T oligo) with sequencing oligo in
PyroMark Annealing Buffer (QIAGEN Inc., Valencia, CA)
and performed Pyrosequencing with sequencing entry
C/TGATC.
Chromatin Immunoprecipitation
ChIP assays were performed as described previously [22].
Briefly, 25 μg crosslinked protein-DNA complexes were
immunoprecipitated using two different histone modifica-
tion antibodies (H3K9ac, H3K9me3: Millipore) and eluted.
Eluted DNA fragments were amplified by PCR. PCR pri-
mer sequences for the multiplex PCR reaction were L1
forward: GCCTTGCAGTTTGATCTCAG and reverse:
GACGGGTGATTTCTGCATTT, AluY8 forward: GTGG
CTCACGCCTGTAATCCCAGC and reverse: GTCGCC
CAGGCCGGACTGCG, and AluJ forward: TGGCTC
ACGCCTGTAATCCCAG and reverse: GCCTCGA
CCTCCCGGGCTCAAGCG. Analyzing density of gel
bands was performed using ImageJ which is a public
domain Java image processing program (http://rsb.info.
nih.gov/ij/).
Results
Screening of AluYa5 insertional polymorphisms in cell
lines
To find insertional polymorphic retrotransposons, we
screened Raji, Jurkat, HT15, H1299, MCF, and K562 cell
lines using the primer sets listed in the Methods section.
The primers flanked the newly inserted retrotransposon
AluYa5 in chr11:100,911,358-100,912,065 locus (Assembly:
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guished by length of PCR amplicon. The PCR amplicon
with fully inserted Alu generates a 476 bp product, while
the amplicon without Alu insertion produces a 150 bp pro-
duct. Among the cell lines we tested, HT15 and H1299
showed two different sizes of bands after PCR amplifica-
tion, indicating Alu has inserted in only one allele of the
genome locus (Figure 1). MCF and K562 showed insertion
of Alu into both alleles (476 bp products). Raji and Jurkat
cell lines, however, did not carry an Alu insertion in either
allele (150 bp products).
Alu insertion dependent DNA cytosine methylation
In order to examine the retrotransposon-derived DNA
methylation spreading theory [23], we determined DNA
methylation status on the Alu-present and Alu-absent
alleles, using the mono-allelic inserted cell lines HT15 and
H1299. The PCR amplicon with bisulfite treated DNA was
digested with the restriction enzyme HpyCH4III, which
cut the 5’..ACNGT..3’ region located on the PCR amplicon
sequence in only the methylated allele (Figure 2A). Both
mono-allelic Alu inserted cell lines, HT15 and H1299,
showed partial digestion of only the Alu-present allele,
indicating DNA methylation exists in only the Alu inserted
allele (Figure 2B). The Alu inserted allele in the H1299 cell
line showed slightly more methylation than the Alu
inserted allele in the HT15 cell line (Figure 2C). We did
not observe digestion of the Alu-absent allele.
Alu insertion derived inactive histone modification
To determine whether Alu insertion causes histone tail
modifications, we performed ChIP-PCR with two histone
modification antibodies against H3K9ac or H3K9me3.
Acetylation at Lys-9 on histone H3 (H3K9ac) is an active
chromatin marker and often associated with positive
gene expression; conversely, methylation at Lys-9 on his-
tone H3 (H3K9me3) is an inactive chromatin marker and
correlated with repressed gene expression [24]. After
Figure 1 Schematic diagram and genotyping of AluYa5 insertion. A) Schematic of mono-allelic AluYa5 insertion in Chromosome 11. The
size of Alu-present allele is 476 bp and Alu-absent allele is 150 bp. The red line is AluYa5 inserted in human genome. Black circles represent CpG
sites. The location of PCR primers are represented in blue arrows. B) The genotyping of Alu insertion. The genomic DNA from six cell lines, Raji,
Jurkat, HT15, H1299, MCF, and K562, are amplified with PCR primer marked above. Single 150 bp bands are generated from bi-allelic Alu-absent
cell lines, 150 bp and 476 bp are from mono-allelic inserted cell lines, and single 476 bp are produced from bi-allelic inserted cell line.
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for active or repressive histone markers, followed by PCR
amplification, we observed differential histone modifica-
tion between Alu-present and Alu-absent alleles. The
active marker H3K9ac is present in only the Alu-absent
allele; however, the inactive histone marker H3K9me3
exists in both allele of the genome locus (Figure 3). This
difference in histone modification has only happened in
young Alu subfamilies, not all Alu subfamilies. ChIP
coupled with PCR amplification of AluJ, AluYb8, and
L1HS showed different distributions of histone modifica-
tions. AluJ, the oldest Alu subfamily, co-located with
both the active marker H3K9ac and the inactive marker
H3K9me3. However, the young Alu subfamily AluYb8
had at least eight times more inactive histone marker
H3K9me3. In addition, human-specific L1HS did not
show a different distribution of active or inactive histone
markers (Figure 4).
Gene expression repressed by Alu insertion in the
genome
To examine differential gene expression in Alu-present
and Alu-absent allele, we developed an allele-specific
gene expression detection method using Pyrosequen-
cing. To distinguish between the two alleles, we geno-
typed the single nucleotide polymorphism (SNP) at
chr11:100921952-100922452 (2009 (GRCh37/hg19)
assembly), reference SNP ID number is rs1042839, since
this SNP is correlated with occurrence of Alu insertion
[25,26]. To confirm this co-existence, we genotyped this
SNP in the six cell lines we worked with and compared
with their Alu insertion statuses (Table 1). Hetero Alu
inserted cell lines HT15 and H1299 showed heterozy-
gote C/T, Alu-absent cell lines Hep3B2 and HL-60 had
a C/C genotype, and Alu-present cell lines MCF and
K562 had a T/T genotype. We confirmed that the
T allele co-exists with Alu insertion, while the C allele
co-exists with the absence of Alu i n s e r t i o ni nh e t e r o
Alu-inserted cell lines. Next, we used this SNP to iden-
tify Alu-inserted alleles for allele-specific gene expres-
sion detection in a Pyrosequencing reaction. After
reverse transcription-PCR with mRNA from the hetero
Alu-inserted cell line H1299, we amplified the locus
flanking the SNP to detect each allelic gene expression
level (Figure 5). Surprisingly, we observed unequal gene
expression levels between Alu-present and Alu-absent
alleles, 10.5% and 89.5% respectively, having an equal
distribution of both alleles in the genome (46.7% of Alu-
present allele vs 53.3% of Alu-absent alleles with geno-
typing data). Thus the presence of Alu in the gene body
repressed gene expression at t h ea l l e l ec o n t a i n i n gt h e
Alu element.
Discussion
We examined the polymorphic inserted young Alu,
AluYa5, in the PGR gene to determine the effects of Alu
Figure 2 Alu insertion dependent restriction enzyme digestion. A) Predicted size and cutting site after restriction enzyme digestion. B)
Agarose gel electrophoresis and C) density of gel bands. Bisulfite-PCR products from mono-allelic Alu inserted cell lines, HT15 and H1299, are
digested with HpyCH4III restriction enzyme. ‘Uncut’ represent a pre-digestion of PCR products which show the intact Alu-present (orange line
and arrow heads) and Alu-absent (dark blue line and arrow heads). ‘HpyCH4III’ represent a post-digestion of PCR products which generate 72 bp
bands (light blue lines and arrow heads) and either 404 bp (green lines and arrow heads) or 78 bp (red lines and arrow heads), depends on the
DNA methylation status in the CpG site. The density of the gel band from Alu-present allele was measured.
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mono-allelic inserted cell lines which carry both Alu-
present and Alu-absent alleles. We observed that the
polymorphic insertion of evolutionally young Alu causes
increasing levels of DNA methylation in the surrounding
genomic area and generates inactive histone tail modifi-
cations. Consequently, the Alu insertion deleteriously
inactivates the neighboring gene expression (Figure 6).
It is a novel approach to address the cis-effects of retro-
transposons or retrotransposition in neighboring geno-
mic structures using a mono-allelic inserted young Alu
subfamily. These effects were observed in a single cell
line system, and virtually all conditions at the particular
locus are the same; the only difference being the presence
or absence of a retrotransposon insertion. Thus this
system bypasses many concerns about experimental arti-
facts being solely responsible for deducing the function
of retrotransposons in the genome.
Generally, our results agree with previous reports that
retrotransposons may repress gene expression through
an epigenetic mechanism. Our study strongly supports
the observations that young active retrotransposons
insert in areas that lack cytosine methylation. Retrotran-
sposons spread DNA methylation into neighboring
regions, generating repressive histone modifications. It
causes a significant inactivation of gene expression. Holl-
ister et al. reported the correlation of transposable ele-
ments and gene silencing; however the caveat was that
the data do not show whether repetitive elements tend to
preferentially insert near lowly expressed genes or
Figure 3 Chromatin Immunoprecipitation assay to assess differential histone modifications on Alu-absent or Alu-present allele.
Representative gel showing chromatin preparations from immunoprecipitated with anti-IgG (lanes 4), anti-H3K9ac (lane 5), anti-H3K9me3 (lane
6), or the negative control non-immune serum (lanes 3). Lane 2 is non-immunoprecipitated DNA. Lane 1 is DNA size marker (A). The density of
the gel band from Alu-present and Alu-absent allele was measured (B). ‘+ Alu’ is the Alu-present allele and ‘- Alu’ represent the Alu-absent allele.
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low gene expression [27]. However, our mono-allelic
inserted cell line system clearly showed that repetitive
elements cause the inactivation of neighboring gene
expression.
It has been estimated that approximately one out of
every 21 births, 212 births, and 916 births has a new inser-
tion of Alu, L1, and SVA retrotransposition, respectively
[10]. Thus there is a great deal of retrotransposition in the
current human genome. It has been know that evolution-
ally young repetitive elements have the capability to retro-
transpose to other genomic locations. In our study, the
Figure 4 Chromatin Immunoprecipitation assay to assess differential histone modifications of global L1HS, young Alu; AluYb8 and old
Alu; AluJ. Representative gel showing chromatin preparations from immunoprecipitated with anti-IgG (lanes 4), anti-H3K9ac (lane 5), anti-
H3K9me3 (lane 6), or the negative control non-immune serum (lanes 3). Lane 2 is non-immunoprecipitated DNA. Lane 1 is DNA size marker (A).
The density of the gel band from L1HS, AluYb8, and AluJ was measured (B).
Table 1 Alu insertion and genotyping in cell lines
Hep3B2 HL-60 HT15 H1299 MCF K562
Alu -/- -/- -/+ -/+ +/+ +/+
SNP CC CC TC TC TT TT
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Alu subfamily and disappeared in the old Alu J subfamily.
Coincidently, global Alu J has less DNA methylation than
the young and active Alu Y family (data not shown).
H e n c et h i se p i g e n e t i cd i f f e r e n c em a yp r o m o t et h e
mechanism that facilitates transposon mobility. However,
what triggers this phenomenon is still not clear, though
environmental cues are believed to be responsible for pro-
moting movement of DNA transposons and retrotranspo-
sons. DNA methylation on retrotransposons is thought to
be an intermediate of the retrotransposition mechanism.
We have observed aberrant cytosine methylation patterns
on retrotransposons with environmental challenges, but
d on o tk n o ww h a tc a u s e st h e s ee v e n t so rw h a tc o n s e -
quences follow them. Based on the observation of our
data, aberrant cytosine methylation on retrotransposons
caused by environmental challenges may trigger retrotran-
sposon mobility, slowly reshaping human genome. In the
future, it will be necessary to understand the function of
other types of retrotransposons of different ages in order
to finally resolve the meaning of this aberrant epigenetic
phenomenon driven by environmental challenge.
Figure 5 Differential level of PGR gene expression on Alu-absent or -present allele. A) PCR combined with Pyrosequencing shows similar
proportion of C (Alu-absent; 53.3%) and T allele (Alu-present; 46.7%) in genomic DNA. Reverse transcription-PCR coupled with Pyrosequencing
shows different proportion of C (Alu-absent; 89.5%) and T allele (Alu-present; 10.5%). B) Representative program of genotyping and gene
expression.
Figure 6 Summary of molecular signature on mono-allelic Alu
insertion. Alu-present allele has cytosine methylation in neighbor
CpG and repressive histone modification. Alu-absent allele shows no
CpG methylation in near CpG site and has additionally active
histone modification, hence show active gene expression.
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The mono-allelic Alu insertion cell line clearly showed
that polymorphic inserted repetitive elements cause the
inactivation of neighboring gene expression, bringing
aberrant epigenetic changes.
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